Curriculum·G802 The SPV and Bankruptcy Remoteness·about 34 min
The claim the token actually represents
By the end of this lesson you can
- →Explain that a token represents a specific legal claim, which may differ from how it is marketed
- →Describe how Lehman Minibonds were credit-linked derivatives sold as safe bonds
- →Reason that the holder's real exposure is defined by the claim's structure, not its name
- →Read a tokenized asset for the exact claim it confers, before trusting its label
Graduate · enrolled learners
This lesson opens with Lehman Brothers Minibonds, 2008.
- What happened
- From 2002 to 2008, retail banks in Hong Kong sold a product called Lehman Brothers Minibonds, under a name that said bond and paying a fixed quarterly coupon above deposit rates, and a similar Lehman-linked Minibond program was sold in Singapore. A Minibond was not a bond. It was a credit-linked note issued by a special-purpose vehicle, Pacific International Finance, and arranged by Lehman Brothers Asia: the investors' money bought collateral held by a trustee, and the vehicle entered credit default and other swaps with a Lehman entity, guaranteed by Lehman Brothers Holdings, linked to the credit of a basket of six to eight reference companies. The holder's return and principal depended on those swaps, the collateral, and Lehman, not on a simple loan to a solid borrower. When Lehman collapsed in September 2008, the swaps terminated, the notes went into early redemption with the holders' recourse limited to the collateral, and the collateral was tied up in the Lehman insolvency; some HK$11.2 billion of Minibonds had been sold to over 33,000 Hong Kong investors, who discovered that the bond they thought they owned was a credit derivative. Most were later made largely whole only through a bank repurchase scheme and a 2011 collateral settlement. The product's name said bond; the claim it actually conferred was a credit-linked derivative exposure to Lehman and a reference basket, and that difference was the risk the holders had not known they carried.
- The decision point
- A token, like any financial instrument, represents a specific legal claim, and the holder's real exposure is defined by the structure of that claim, not by the name on the product. The claim could be direct ownership of an asset, a debt claim on an issuer, a beneficial interest in an SPV, a derivative exposure referencing something else, and each carries a completely different risk, even when marketed under a comforting label. Lehman Minibonds is the case: sold as safe bonds, they were in substance credit-linked derivatives whose value depended on Lehman and a reference basket, so holders bore a risk entirely unlike the one the name implied, and when Lehman failed the gap between the label and the claim became the holders' exposure. For a tokenized real-world asset, the token's holder needs to know exactly what claim the token confers, on what, ranking where, dependent on whose performance, because that is their actual exposure. So the decision when structuring or holding a tokenized asset is to read the token for the precise claim it represents and trace where its value really comes from, rather than trusting the product name, because the name is marketing and the claim is the risk, and Lehman Minibonds is what it costs when a holder owns the label and not an understanding of the claim.
- Recorded loss
- $1,440,000,000
What you will be able to answer
- →What was a Lehman Minibond actually (2008)?
- →What defines a token holder's real exposure?
- →Why can similarly-named tokens carry different risk?
- →What must a holder of a tokenized asset know?
Orientation and Year One are open: anyone can read them without an account. From Year Two onward the lessons are for enrolled learners, because progress through the later years only means anything if it is tracked against a record.
It is free. We do not sell the list and there is nothing to buy at the end of it.
Sources and review
- https://www.legco.gov.hk/yr08-09/english/hc/sub_com/hs01/report/ch2-e.pdf
- https://www.legco.gov.hk/yr08-09/english/hc/sub_com/hs01/report/ch5-e.pdf
- https://www.hkma.gov.hk/eng/news-and-media/press-releases/2009/07/20090722-4/
- https://www.hkma.gov.hk/eng/news-and-media/press-releases/2011/06/20110614-7
- https://www.mas.gov.sg/news/media-releases/2009/mas-releases-investigation-findings-on-the-sale-and-marketing-of-structured-notes-linked-to-lehman-brothers
Confidence high·Volatility low·Reviewed 2026-09-16·Owner unassigned
Contested
The figure is exposure, not realized loss. The Legislative Council subcommittee report, citing the HKMA's review, says some HK$11.2 billion of Minibonds had been sold to over 33,000 Hong Kong investors (about 1.44 billion US dollars at the HK$7.8 peg, which is loss_usd), out of over HK$20.23 billion of Lehman structured products sold to more than 43,700 investors through retail banks; Singapore's separate Minibond Notes are not counted. Under the July 2009 SFC, HKMA and 16-bank agreement the banks offered eligible customers 60 percent of nominal value (70 percent for those 65 or older), and the HKMA's June 2011 release says the collateral settlement with Lehman Brothers Special Financing lifted eligible customers' recovery in series 10 to 12, 15 to 23 and 25 to 36 to between 85.7 and 97.5 percent of their initial investment; series 5 to 7 and 9, whose collateral was Lehman-issued debt, were not covered. So the Minibonds did not become worthless, and the label-versus-claim point is the lesson's, not a loss total.
That the Minibonds were marketed as safe is contested. The subcommittee found the prospectuses said they were not principal protected and not suitable for everyone, while it also found inconsistent bank risk ratings, one bank rating similar Lehman credit-linked notes low to medium risk, and many buyers aged 65 or above; mis-selling was the subject of its inquiry. The lesson rests on what the name said, not on any finding that every sale was misleading.
Minibonds are a structured-product example, not a token, but the principle, that the holder's exposure is the claim's structure and not the product name, applies directly to tokenized assets, where the same gap between a marketed label and the underlying claim can arise.
